TrianglePUBLICATIONS · 26140243
Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-G(D2) immunotherapy and isotretinoin: a prospective Phase II study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Oncoimmunology
- Publication date
- 2015 Jul
- First author
- Kushner BH
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Kushner BH
- type
- Author
- name
- Ostrovnaya I
- type
- Author
- name
- Cheung IY
- type
- Author
- name
- Kuk D
- type
- Author
- name
- Kramer K
- type
- Author
- name
- Modak S
- type
- Author
- name
- Yataghene K
- type
- Author
- name
- Cheung NK
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Kushner BH
- type
- Author
- name
- Ostrovnaya I
- type
- Author
- name
- Cheung IY
- type
- Author
- name
- Kuk D
- type
- Author
- name
- Kramer K
- type
- Author
- name
- Modak S
- type
- Author
- name
- Yataghene K
- type
- Author
- name
- Cheung NK
- type
- Author
- bibliography ids
- nci-bib-cbf729a470a0660bb48c2716
- book metadata
- content sha256
- 8cedc05fb1d378e4ec265ef045c79684756dbb4789f48ce982ca09355561fc93
- document type
- citation
- dois
- 10.1080/2162402X.2015.1016704
- electronic publication date
- display
- 2015 May 22
- precision
- day
- year
- 2015
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:26140243
- immutable id
- pubmed:26140243@8cedc05fb1d378e4ec265ef045c79684756dbb4789f48ce982ca09355561fc93
- journal
- abbreviation
- Oncoimmunology
- issn electronic
- 2162-402X
- issn print
- 2162-4011
- issue
- 7
- name
- Oncoimmunology
- nlm unique id
- 101570526
- pages
- e1016704
- volume
- 4
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 26140243
- provenance
- batch id
- 4c1ece5bfc3d8e2be622
- provider
- NCBI PubMed ESummary
- record sha256
- e9ed5e60f58a52e4e99fc1d76d53f46e0c9649adf6a563bedc814cc8f9a23b04
- response sha256
- 85f81bf7b60c457e4b5806b47c7c67c745ada2ae114069aa45de5ef977770dba
- retrieved at
- 2026-09-09T23:47:12.730551+00:00
- publication date
- display
- 2015 Jul
- precision
- month
- year
- 2015
- publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- Research Support, N.I.H., Extramural
- record status
- PubMed
- schema version
- 1.0
- title
- Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-G(D2) immunotherapy and isotretinoin: a prospective Phase II study.
Preserved source evidence · Not medical advice